sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals Asia-Pacific Dermatology OTC Medications Market...

Asia-Pacific Dermatology OTC Medications Market Forecast to 2028 – COVID-19 Impact and Analysis – by Product Type (Tablets and Capsules, Gels, Creams and Ointments, and Others), Route of Administration (Topical and Oral), Indication (Dermatitis, Acne, Psoriasis, Skin Bleaching, Fungal Disease, Warts, and Others), and Distribution Channel (Online Distribution and Offline Distribution) 

BMIRE00025070 | Pages: 214 | Pharmaceuticals | Jun 2022 | Type: Regional | Status: Published

The APAC dermatology OTC medications market is expected to grow from US$ 3,496.75 million in 2021 to US$ 5,296.25 million by 2028; it is estimated to grow at a CAGR of 6.1% from 2021 to 2028.

According to Statista, the OTC pharmaceuticals market generated US$ 3,773 million in November 2018. In 2018, the average revenue per person in the OTC pharmaceuticals industry was US$ 2.79. Similarly, the OTC market was worth US$ 125 billion in 2019 and is expected to grow at a rate of 4–5% over the next few years, according to The Lubrizol Corporation firm. Some patients continue to use brand-name prescriptions despite the cost difference due to perceptions or previous experiences with generic medications, increasing consumer spending, patient discontent, and declining adherence. Higher competition in the generic product industry lower drug prices and increases access to affordable healthcare. Generics are typically 80‒85% cheaper than branded products. According to the one association, 4 billion generic prescriptions were filled in 2018, accounting for 90% of all prescriptions filled in the countries across the region. However, this accounted for only 22% of total medication spending. Thus, the growing OTC drugs market will create lucrative opportunities for the APAC dermatology OTC medications market.

 

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the APAC dermatology OTC medications market. The APAC dermatology OTC medications market is expected to grow at a good CAGR during the forecast period. 

 

APAC Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)    

APAC Dermatology OTC Medications Market Revenue and Forecast to 2028 (US$ Million)    

Get more information on this report :


APAC Dermatology OTC Medications Market Segmentation       

 

The APAC dermatology OTC medications market is segmented into product type, route of administration, indication, distribution channel, and country. Based on product type, the market is segmented into tablets and capsules, gels, creams and ointments, and others. The creams and ointments segment dominated the market in 2020; however, the tablets and capsules segment is expected to be fastest growing segment during the forecast period. Based on route of administration, the market is segmented into topical and oral. The topical segment dominated the market in 2020; however, the oral segment is expected to be a faster growing segment during the forecast period. Based on indication, the market is segmented into dermatitis, acne, psoriasis, skin bleaching, fungal disease, warts, and others. The acne segment dominated the market in 2020 and is expected to be the fastest growing during the forecast period. The dermatitis segment is further segmented into atopic dermatitis, contact dermatitis, and others. The acne segment is further segmented into non-inflammatory acne and inflammatory acne. The psoriasis segment is sub segmented into plaque psoriasis, guttate psoriasis, and others. The fungal disease is further segmented into athlete's foot, ringworm, fungal nail infections, and others. Moreover, the warts segment is further segmented into common warts, flat warts, and others. Based on distribution channel, the market is segmented into online distribution and offline distribution. The offline distribution segment dominated the market in 2020; however, the online distribution segment is expected to be a faster growing segment during the forecast period. The offline distribution is further segmented into retail and hospital pharmacies and super and hypermarkets. Based on country, the market is segmented into China, India, Japan, South Korea, Australia, and the Rest of APAC.      

 

Bausch Health Companies Inc.; Bayer AG; Dr. Reddy's Laboratories; Galderma; GlaxoSmithKline plc.; Johnson and Johnson Services, Inc.; LEO Pharma A/S; Perrigo Company plc; and Viatris Inc. are among the leading companies in the APAC dermatology OTC medications market. 

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        APAC Dermatology OTC Medications Market – By Product Type

1.3.2        APAC Dermatology OTC Medications Market – By Route of Administration

1.3.3        APAC Dermatology OTC Medications Market – By Indication

1.3.4        APAC Dermatology OTC Medications Market – By Distribution Channel

1.3.5        APAC Dermatology OTC Medications Market – By Country

2.           Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           APAC Dermatology OTC Medications Market – Market Landscape

4.1         Overview

4.2         APAC PEST Analysis

4.3         Experts Opinion

5.           APAC Dermatology OTC Medications Market – Key Market Dynamics

5.1         Key Market Drivers

5.1.1        Surging Prevalence of Skin Problems

5.1.2        Escalating Income of Middle-class Population

5.2         Market Restraints

5.2.1        Inappropriate Use of OTC Medications

5.3         Market Opportunities

5.3.1        Rising OTC Market

5.4         Future Trends

5.4.1        Growing Transition from Rx to OTC

5.5         Impact Analysis of Drivers and Restraints

6.           Dermatology OTC Medications Market– APAC Analysis

6.1         APAC Dermatology OTC Medications Market Revenue Forecast and Analysis

7.           APAC Dermatology OTC Medications Market Analysis – By Product Type

7.1         Overview

7.2         APAC Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)

7.3         Tablets and Capsules

7.3.1        Overview

7.3.2        Tablets and Capsules Market Revenue and Forecast to 2028 (US$ million)

7.4         Gels

7.4.1        Overview

7.4.2        Gels Market Revenue and Forecast to 2028 (US$ million)

7.5         Creams and Ointments

7.5.1        Overview

7.5.2        Creams and Ointments Market Revenue and Forecast to 2028 (US$ million)

7.6         Others

7.6.1        Overview

7.6.2        Others Market Revenue and Forecast to 2028 (US$ million)

8.           APAC Dermatology OTC medications Market Analysis – By Route of Administration

8.1         Overview

8.2         APAC Dermatology OTC Medications Market Share, by Route of Administration, 2021 and 2028 (%)

8.3         Topical

8.3.1        Overview

8.3.2        Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

8.4         Oral

8.4.1        Overview

8.4.2        Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.           APAC Dermatology OTC Medications Market Analysis – By Indication

9.1         Overview

9.2         APAC Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)

9.3         Dermatitis

9.3.1        Overview

9.3.2        Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.3        Atopic Dermatitis

9.3.3.1          Overview

9.3.3.2          Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.4        Contact Dermatitis

9.3.4.1          Overview

9.3.4.2          Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.3.5        Others

9.3.5.1          Overview

9.3.5.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4         Acne

9.4.1        Overview

9.4.2        Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4.3        Non-Inflammatory Acne

9.4.3.1          Overview

9.4.3.2          Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.4.4        Inflammatory Acne

9.4.4.1          Overview

9.4.4.2          Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5         Psoriasis

9.5.1        Overview

9.5.2        Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.3        Plaque Psoriasis

9.5.3.1          Overview

9.5.3.2          Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.4        Guttate Psoriasis

9.5.4.1          Overview

9.5.4.2          Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.5.5        Others

9.5.5.1          Overview

9.5.5.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.6         Skin Bleaching

9.6.1        Overview

9.6.2        Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7         Fungal Disease

9.7.1        Overview

9.7.2        Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.3        Athlete's Foot

9.7.3.1          Overview

9.7.3.2          Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.4        Ringworm

9.7.4.1          Overview

9.7.4.2          Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.5        Fungal Nail Infections

9.7.5.1          Overview

9.7.5.2          Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.7.6        Others

9.7.6.1          Overview

9.7.6.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8         Warts

9.8.1        Overview

9.8.2        Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.3        Common Warts

9.8.3.1          Overview

9.8.3.2          Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.4        Flat Warts

9.8.4.1          Overview

9.8.4.2          Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.8.5        Others

9.8.5.1          Overview

9.8.5.2          Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

9.9         Others

9.9.1        Overview

9.9.2        Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.        APAC Dermatology OTC medications Market Analysis – By Distribution Channel

10.1      Overview

10.2      APAC Dermatology OTC Medications Market Share, by Distribution Channel, 2021 and 2028 (%)

10.3      Online Distribution

10.3.1     Overview

10.3.2     Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4      Offline Distribution

10.4.1     Overview

10.4.2     Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4.3     Retail and Hospital Pharmacies

10.4.3.1       Overview

10.4.3.2       Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

10.4.4     Super and Hyper Markets

10.4.4.1       Overview

10.4.4.2       Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

11.        APAC Dermatology OTC Medications Market Revenue and Forecasts to 2028 – Country Analysis

11.1      APAC: Dermatology OTC Medications Market

11.1.1     Overview

11.1.3     APAC: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

11.1.4     China: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.4.1       China: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.4.2       China: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.4.3       China: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.1.4.4       China: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.1.4.4.1       China: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.1.4.4.2       China: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.1.4.4.3       China: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.1.4.4.4       China: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.1.4.4.5       China: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.1.4.5       China: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.1.4.5.1       China: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.5     Japan: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.5.1       Japan: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.5.2       Japan: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.5.3       Japan: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.1.5.4       Japan: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.1.5.4.1       Japan: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.1.5.4.2       Japan: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.1.5.4.3       Japan: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.1.5.4.4       Japan: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.1.5.4.5       Japan: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.1.5.5       Japan: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.1.5.5.1       Japan: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.6     India: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.1       India: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.6.2       India: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.6.3       India: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.1.6.3.1       India: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.1.6.3.2       India: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.1.6.3.3       India: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.1.6.3.4       India: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.1.6.3.5       India: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.1.6.3.6       India: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.1.6.4       India: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.1.6.4.1       India: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.7     Australia: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.1       Australia: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.7.2       Australia: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.7.3       Australia: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.1.7.4       Australia: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.1.7.4.1       Australia: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.1.7.4.2       Australia: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.1.7.4.3       Australia: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.1.7.4.4       Australia: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.1.7.4.5       Australia: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.1.7.5       Australia: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.1.7.5.1       Australia: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.8     South Korea: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.1       South Korea: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.8.2       South Korea: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.8.3       South Korea: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.1.8.4       South Korea: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.1.8.4.1       South Korea: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.1.8.4.2       South Korea: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.1.8.4.3       South Korea: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.1.8.4.4       South Korea: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.1.8.4.5       South Korea: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.1.8.5       South Korea: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.1.8.5.1       South Korea: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

11.1.9     Rest of APAC: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.1       Rest of APAC: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

11.1.9.2       Rest of APAC: Dermatology OTC Medications Market, by Product Type, 2019–2028 (USD Million)

11.1.9.3       Rest of APAC: Dermatology OTC Medications Market, By Route of Administration,2019–2028 (USD Million)

11.1.9.4       Rest of APAC: Dermatology OTC Medications Market, By Indication, 2019–2028 (USD Million)

11.1.9.4.1       Rest of APAC: Dermatology OTC Medications Market, by Acne Indication, 2019–2028 (USD Million)

11.1.9.4.2       Rest of APAC: Dermatology OTC Medications Market, by Dermatitis Indication, 2019–2028 (USD Million)

11.1.9.4.3       Rest of APAC: Dermatology OTC Medications Market, by Fungal Diseases Indication, 2019–2028 (USD Million)

11.1.9.4.4       Rest of APAC: Dermatology OTC Medications Market, by Psoriasis Indication, 2019–2028 (USD Million)

11.1.9.4.5       Rest of APAC: Dermatology OTC Medications Market, by Warts Indication, 2019–2028 (USD Million)

11.1.9.5       Rest of APAC: Dermatology OTC Medications Market, By Distribution Channel, 2019–2028 (USD Million)

11.1.9.5.1       Rest of APAC: Dermatology OTC Medications Market, by Offline Distribution, 2019–2028 (USD Million)

12.        Industry Landscape

12.1      Overview

12.2      Inorganic Growth Strategies

12.2.1     Overview

12.3      Organic Growth Strategies

12.3.1     Overview

13.        Company Profiles

13.1      Bausch Health Companies Inc.

13.1.1     Key Facts

13.1.2     Business Description

13.1.3     Products and Services

13.1.4     Financial Overview

13.1.5     SWOT Analysis

13.1.6     Key Developments

13.2      Perrigo Company plc

13.2.1     Key Facts

13.2.2     Business Description

13.2.3     Products and Services

13.2.4     Financial Overview

13.2.5     SWOT Analysis

13.2.6     Key Developments

13.3      Bayer AG

13.3.1     Key Facts

13.3.2     Business Description

13.3.3     Products and Services

13.3.4     Financial Overview

13.3.5     SWOT Analysis

13.3.6     Key Developments

13.4      Viatris Inc.

13.4.1     Key Facts

13.4.2     Business Description

13.4.3     Products and Services

13.4.4     Financial Overview

13.4.5     SWOT Analysis

13.4.6     Key Developments

13.5      Johnson and Johnson Services, Inc.

13.5.1     Key Facts

13.5.2     Business Description

13.5.3     Products and Services

13.5.4     Financial Overview

13.5.5     SWOT Analysis

13.5.6     Key Developments

13.6      LEO Pharma A/S

13.6.1     Key Facts

13.6.2     Business Description

13.6.3     Products and Services

13.6.4     Financial Overview

13.6.5     SWOT Analysis

13.6.6     Key Developments

13.7      GlaxoSmithKline plc.

13.7.1     Key Facts

13.7.2     Business Description

13.7.3     Products and Services

13.7.4     Financial Overview

13.7.5     SWOT Analysis

13.7.6     Key Developments

13.8      Galderma

13.8.1     Key Facts

13.8.2     Business Description

13.8.3     Products and Services

13.8.4     Financial Overview

13.8.5     SWOT Analysis

13.8.6     Key Developments

13.9      Dr. Reddy's Laboratories

13.9.1     Key Facts

13.9.2     Business Description

13.9.3     Products and Services

13.9.4     Financial Overview

13.9.5     SWOT Analysis

13.9.6     Key Developments

14.        Appendix

14.1      Glossary of Terms 

LIST OF TABLES

Table 1.             APAC Dermatology OTC Medications Market, Revenue and Forecast, 2019–2028 (US$ Mn)

Table 2.             China: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 3.             China: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 4.             China: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 5.             China: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 6.             China: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 7.             China: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 8.             China: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 9.             China: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 10.          China: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 11.          China: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 12.          Japan: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 13.          Japan: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 14.          Japan: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 15.          Japan: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 16.          Japan: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 17.          Japan: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 18.          Japan: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028  (USD Million)

Table 19.          Japan: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 20.          Japan: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 21.          Japan: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 22.          India: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 23.          India: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 24.          India: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 25.          India: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 26.          India: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 27.          India: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 28.          India: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 29.          India: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 30.          India: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 31.          India: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 32.          Australia: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 33.          Australia: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 34.          Australia: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 35.          Australia: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 36.          Australia: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 37.          Australia: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 38.          Australia: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 39.          Australia: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 40.          Australia: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 41.          Australia: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 42.          South Korea: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 43.          South Korea: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 44.          South Korea: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 45.          South Korea: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 46.          South Korea: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 47.          South Korea: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 48.          South Korea: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 49.          South Korea: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 50.          South Korea: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 51.          South Korea: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 52.          Rest of APAC: Dermatology OTC Medications Market, by Product Type – Revenue and Forecast to 2028 (USD Million)

Table 53.          Rest of APAC: Dermatology OTC Medications Market, By Route of Administration – Revenue and Forecast to 2028 (USD Million)

Table 54.          Rest of APAC: Dermatology OTC Medications Market, By Indication – Revenue and Forecast to 2028 (USD Million)

Table 55.          Rest of APAC: Dermatology OTC Medications Market, by Acne Indication – Revenue and Forecast to 2028 (USD Million)

Table 56.          Rest of APAC: Dermatology OTC Medications Market, by Dermatitis Indication – Revenue and Forecast to 2028 (USD Million)

Table 57.          Rest of APAC: Dermatology OTC Medications Market, by Fungal Diseases Indication – Revenue and Forecast to 2028 (USD Million)

Table 58.          Rest of APAC: Dermatology OTC Medications Market, by Psoriasis Indication – Revenue and Forecast to 2028 (USD Million)

Table 59.          Rest of APAC: Dermatology OTC Medications Market, by Warts Indication – Revenue and Forecast to 2028 (USD Million)

Table 60.          Rest of APAC: Dermatology OTC Medications Market, By Distribution Channel – Revenue and Forecast to 2028 (USD Million)

Table 61.          Rest of APAC: Dermatology OTC Medications Market, by Offline Distribution – Revenue and Forecast to 2028 (USD Million)

Table 62.          Recent Inorganic Growth Strategies

Table 63.          Recent Organic Growth Strategies

Table 64.          Glossary of Terms

 


LIST OF FIGURES

Figure 1.           APAC Dermatology OTC Medications Market Segmentation

Figure 2.           APAC Dermatology OTC Medications Market, By Country

Figure 3.           APAC Dermatology OTC Medications Market Overview

Figure 4.           Creams and Ointments Segment Held the Largest Share of the Market in 2021

Figure 5.           China held the Largest Share of the Market in 2021

Figure 6.           APAC: PEST Analysis

Figure 7.           Experts Opinion

Figure 8.           APAC Dermatology OTC Medications Market Impact Analysis of Drivers and Restraints

Figure 9.           APAC Dermatology OTC Medications Market – By Forecast and Analysis

Figure 10.        APAC Dermatology OTC Medications Market Share by Product Type, 2021 & 2028 (%)

Figure 11.        APAC Tablets and Capsules Market Revenue and Forecasts to 2028 (US$ million)

Figure 12.        APAC Gels Market Revenue and Forecasts to 2028 (US$ million)

Figure 13.        APAC Creams and Ointments Market Revenue and Forecasts to 2028 (US$ million)

Figure 14.        APAC Others Market Revenue and Forecasts to 2028 (US$ million)

Figure 15.        APAC Dermatology OTC Medications market Share, by Route of Administration, 2021 and 2028 (%)

Figure 16.        APAC Topical: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 17.        APAC Oral: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 18.        APAC Dermatology OTC Medications Market Share, by Indication, 2021 and 2028 (%)

Figure 19.        APAC Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 20.        APAC Atopic Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 21.        APAC Contact Dermatitis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 22.        APAC Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 23.        APAC Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 24.        APAC Non-Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 25.        APAC Inflammatory Acne: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 26.        APAC Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 27.        APAC Plaque Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 28.        APAC Guttate Psoriasis: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 29.        APAC Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 30.        APAC Skin Bleaching: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 31.        APAC Fungal Disease: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 32.        APAC Athlete's Foot: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 33.        APAC Ringworm: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 34.        APAC Fungal Nail Infections: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 35.        APAC Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 36.        APAC Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 37.        APAC Common Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 38.        APAC Flat Warts: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 39.        APAC Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 40.        APAC Others: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 41.        APAC Dermatology OTC Medications market Share, by Distribution Channel, 2021 and 2028 (%)

Figure 42.        APAC Online Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 43.        APAC Offline Distribution: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 44.        APAC Retail and Hospital Pharmacies: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 45.        APAC Super and Hyper Markets: Dermatology OTC Medications Market– Revenue and Forecast to 2028 (US$ Million)

Figure 46.        APAC: Dermatology OTC Medications Market, by Key Country – Revenue (2021) (USD Million)

Figure 47.        APAC: Dermatology OTC Medications Market, by Country, 2021 & 2028 (%)

Figure 48.        China: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 49.        Japan: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 50.        India: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 51.        Australia: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 52.        South Korea: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

Figure 53.        Rest of APAC: Dermatology OTC Medications Market – Revenue and Forecast to 2028 (USD Million)

  1. Bausch Health Companies Inc.
  2. Bayer AG
  3. Dr. Reddy's Laboratories
  4. Galderma
  5. GlaxoSmithKline plc.
  6. Johnson and Johnson Services, Inc.
  7. LEO Pharma A/S     
  8. Perrigo Company plc
  9. Viatris Inc.  
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the APAC dermatology OTC medications market.        
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The key findings and recommendations highlight crucial progressive industry trends in the APAC dermatology OTC medications market, thereby allowing players across the value chain to develop effective long-term strategies
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
  • Scrutinize in-depth APAC market trends and outlook coupled with the factors driving the dermatology OTC medications market, as well as those hindering it
  • Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution  
Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an.. May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec.. May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an.. May 2022
Purchase Options
Single User License
$3000
$2400
Site License
$4000
$3200
Enterprise License
$5000
$4000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription